Market News & Trends
Nuevolution Announces Exclusive License Agreement
Nuevolution A/S recently announced that it has entered an exclusive license agreement with a subsidiary of Merck & Co., Inc., known as MSD outside the…
Roche Signs Licensing Agreement with Sysmex Inostics GmbH
Roche recently announced a licensing agreement with Sysmex Inostics GmbH for its emPCR portfolio of patents. Under the terms of the licensing agreement, Roche grants…
Type 2 Diabetes Next-Generation Therapeutics Create Vast Opportunities in Europe
Type 2 diabetes is one of the most significant global health concerns of modern times. According to the International Diabetes Federation, more than 55 million…
Actavis to Buy Forest for $25 Billion
Generic drugmaker Actavis Plc said on Tuesday it would buy Forest Laboratories Inc. for about $25 billion in cash and stock, expanding its portfolio of…
Zosano Strikes $115-Million+ Plus Deal
Zosano Pharma, Inc. recently announced it has entered into an agreement with Novo Nordisk to develop a new transdermal presentation of semaglutide, an investigational proprietary…
Sonrgy Secures Exclusive License to Commercialize Drug Delivery Nanotechnology
Sonrgy, Inc. recently announced it has entered into an exclusive license agreement with the University of California for the company’s core technology, an ultrasound-sensitive drug…
West Expands as a Result of Securing Significant Customer Program
Tech Group Europe, a leading medical device manufacturer based in Mulhuddart, Dublin, Ireland, serving the pharmaceutical and medical industries, is expanding its Dublin manufacturing and…
Type 2 Diabetes Next-Generation Therapeutics Create Vast Opportunities in Europe
Type 2 diabetes is one of the most significant global health concerns of modern times. According to the International Diabetes Federation, more than 55 million…
Mayne Pharma USA Acquires Branded Products
Mayne Pharma USA has begun expanding its North American product portfolio by acquiring well-known branded pharmaceuticals used to treat pain. The company announced it has…
Horizon Discovery Signs Major Agreements; Launches GENASSIST Line of Kits & Reagents
Horizon Discovery recently announced it has signed a worldwide distribution agreement with Haplogen GmbH, with immediate effect. Under the terms of the agreement, customers can…
WellSpring Pharma Services Expands Business Development Capabilities
WellSpring Pharma Services recently announced the addition of Mr. Lonnie Barish, MBA, as Executive Director, Business Development, and Mr. David Watt as Technical Director, Pharma…
EMD MilliporeLaunches New System for More Powerful Benchtop Cell Analysis
EMD Millipore, the Life Science division of Merck KGaA of Darmstadt, Germany, recently launched the guava easyCyte 12 flow cytometry system, which provides a simple…
Domain Therapeutics Enters Collaboration With XOMA
Domain Therapeutics recently announced it has entered into a multi-step collaboration with XOMA Corporation. XOMA focuses its research on allosteric modulation, which offers opportunities for…
Merck & Ablynx Sign Global Agreement
Ablynx recently announced it has entered into a second research collaboration and licensing agreement with a subsidiary of Merck & Co., known outside the US…
Aptar Presents Latest User-Study Results for Auto-Injector
Aptar Pharma Prescription Division will present and discuss the latest data from a number of user studies carried out with its Pro-Ject auto-injector at the…
Lupin Acquires Nanomi, Heading Toward Complex Injectables Space
Pharmaceutical major Lupin Limited recently announced the acquisition of Nanomi B.V. in the Netherlands. With this acquisition, Lupin has made its foray into the technology…
A Silk Coat for Diamonds Makes Sleek New Imaging and Drug Delivery Tool
Silk and diamonds aren't just for ties and jewelry anymore. They're ingredients for a new kind of tiny glowing particle that could provide doctors and…
Novozymes Biopharma Announces New Data Highlighting Potential for Monthly Drug Dosing
Novozymes Biopharma recently announced new data on extending the serum half-life of albumin in vivo. This compelling data set, recently presented at PepTalk 2014, demonstrates…
Strong Pipeline of Monoclonal Antibodies Biosimilars in the US & Europe Lends Impetus to Global Market
The imminent entry of several companies, including big pharma, small biotech, and generic participants, into the global biosimilars space will propel the market toward exponential…
Gerresheimer Develops Interface for Integrating Glass Syringes in Autoinjectors
The development of autoinjectors generally involves the integration of a prefilled glass syringe into a plastic drug delivery device - a major challenge due to…
